Humans
Mycobacterium abscessus
Mycobacterium Infections, Nontuberculous
/ drug therapy
Anti-Bacterial Agents
/ pharmacology
Clarithromycin
/ pharmacology
Amikacin
/ pharmacology
Anti-Infective Agents
/ pharmacology
Mycobacterium
Rifabutin
/ pharmacology
Tetracyclines
/ pharmacology
Microbial Sensitivity Tests
Mycobacterium abscessus
checkerboard method
nontuberculous mycobacteria
omadacycline
synergy
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
15 06 2023
15 06 2023
Historique:
medline:
19
6
2023
pubmed:
8
5
2023
entrez:
8
5
2023
Statut:
ppublish
Résumé
The clinical importance of Mycobacterium abscessus species (MABS) infections has been increasing. However, the standard treatment regimens recommended in the current guidelines often result in unfavorable outcomes. Therefore, we investigated the
Identifiants
pubmed: 37154742
doi: 10.1128/aac.01579-22
pmc: PMC10269086
doi:
Substances chimiques
omadacycline
090IP5RV8F
Anti-Bacterial Agents
0
Clarithromycin
H1250JIK0A
Amikacin
84319SGC3C
Anti-Infective Agents
0
Rifabutin
1W306TDA6S
Tetracyclines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0157922Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Antimicrob Agents Chemother. 2014;58(2):1127-35
pubmed: 24295985
Antimicrob Agents Chemother. 2020 Jan 27;64(2):
pubmed: 31767722
Antimicrob Agents Chemother. 2019 Mar 27;63(4):
pubmed: 30670428
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28696233
Microbiol Spectr. 2021 Dec 22;9(3):e0192821
pubmed: 34878300
Microbiol Spectr. 2022 Jun 29;10(3):e0057122
pubmed: 35446117
Antimicrob Agents Chemother. 2017 Oct 24;61(11):
pubmed: 28807911
Antimicrob Agents Chemother. 2021 Feb 17;65(3):
pubmed: 33288634
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0170421
pubmed: 34662184
Eur Respir J. 2019 Jul 11;54(1):
pubmed: 30880280
Sci Adv. 2017 Oct 11;3(10):e1701881
pubmed: 29026882
J Antimicrob Chemother. 2020 Mar 1;75(3):609-617
pubmed: 31886864
Chest. 2022 Jan;161(1):64-75
pubmed: 34314673
Int J Antimicrob Agents. 2013 Sep;42(3):226-31
pubmed: 23850022
Diagn Microbiol Infect Dis. 2014 Jul;79(3):331-6
pubmed: 24809859
Chest. 2017 Jul;152(1):120-142
pubmed: 28461147
Front Pharmacol. 2021 Dec 08;12:790767
pubmed: 34955859
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28396540
Int J Syst Evol Microbiol. 2006 Jan;56(Pt 1):133-43
pubmed: 16403878
Clin Chest Med. 2015 Mar;36(1):13-34
pubmed: 25676516
J Clin Microbiol. 2014 Jan;52(1):251-9
pubmed: 24197885
J Antimicrob Chemother. 2019 Oct 1;74(10):2930-2933
pubmed: 31236595
J Clin Microbiol. 1991 Aug;29(8):1596-603
pubmed: 1761680
Lancet Infect Dis. 2022 Jul;22(7):e178-e190
pubmed: 35090639
Lancet Infect Dis. 2019 Oct;19(10):1080-1090
pubmed: 31474458
Antimicrob Agents Chemother. 2017 May 24;61(6):
pubmed: 28348153
Microbiol Spectr. 2022 Jun 29;10(3):e0009722
pubmed: 35536059
Antimicrob Agents Chemother. 2011 Feb;55(2):775-81
pubmed: 21135185
Clin Infect Dis. 2020 Aug 14;71(4):905-913
pubmed: 32797222
J Antimicrob Chemother. 2017 Feb;72(2):625-628
pubmed: 27999019
Eur Respir J. 2015 Apr;45(4):1177-9
pubmed: 25614169
J Clin Microbiol. 2015 Apr;53(4):1211-5
pubmed: 25653399
Clin Infect Dis. 2019 Aug 1;69(Suppl 1):S16-S22
pubmed: 31367744
Antimicrob Agents Chemother. 2020 Jun 23;64(7):
pubmed: 32312777
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30104268
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29760147
Antimicrob Agents Chemother. 2020 Oct 20;64(11):
pubmed: 32816730
Open Forum Infect Dis. 2021 Jan 07;8(2):ofab002
pubmed: 33628856
Ann Am Thorac Soc. 2017 Jan;14(1):49-56
pubmed: 27788025
Clin Infect Dis. 2017 Feb 1;64(3):309-316
pubmed: 28011608
Thorax. 2017 Nov;72(Suppl 2):ii1-ii64
pubmed: 29054853
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858221